Table 7.
Zone of Inhibition in mm (using 50 μg ml−1 as test solution)
Compound | Antibacterial activity | Antifungal activity | ||||||
---|---|---|---|---|---|---|---|---|
S. aureus | B. subtilis | K. pneumoniae | E. coli | P. vulgaris | S. typhi | A. niger | C. albicans | |
4a | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ |
4b | +++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ |
5a | ++ | ++ | ++ | ++ | +++ | +++ | +++ | +++ |
5b | ++ | +++ | ++ | +++ | ++ | ++ | ++ | ++ |
5c | ++ | ++ | ++ | ++ | +++ | +++ | ++ | ++ |
5d | +++ | +++ | ++ | +++ | ++ | +++ | ++ | ++ |
5e | ++ | ++ | ++ | ++ | +++ | ++ | ++ | +++ |
5f | +++ | +++ | ++ | +++ | +++ | +++ | +++ | +++ |
5g | ++ | ++ | ++ | ++ | +++ | +++ | ++ | ++ |
5h | ++ | ++ | ++ | +++ | ++ | ++ | ++ | ++ |
Ofloxacin | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | – | – |
Fluconazole | – | – | – | – | – | – | ++++ | ++++ |
Control | + | + | + | + | + | + | + | + |
++++ (31–36), +++ (21–30), ++ (11–20), + (8–10) in mm